Sponsor: Horizon Pharma
Protocol Number: HZNP-KRY-403
|
The purpose of this study is to assess the safety, tolerability, and efficiency of pegloticase administered with a shorter infusion duration in participants with uncontrolled gout receiving methotrexate. |
Detailed Information: Here
To learn more or see if you qualify: Click Here
Sponsor: LG Chem, LTD
Protocol Number: LG-GDCL010
|
The aim of this 12-month randomized multi-regional double-blind parallel group allopurinol and placebo-controlled phase 3 study is to assess the efficacy and safety of three different doses of Tigulixostat in gout patients with hyperuricemia. |
Detailed Information: Here
To learn more or see if you qualify: Click Here